IP Library Granted Patent US 9,080,151
Granted Patent B2
US 9,080,151 · App. 13/068,285 · Granted Jul 14, 2015

Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells

Inventors: Su-Chun Zhang (Middleton, WI); Xue-jun Li (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N5/0623A61K35/12C12N2500/25C12N2501/115C12N2501/119C12N2501/392C12N2501/91C12N2502/13C12N2506/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,080,151
App. No.
13/068,285
Granted
Jul 14, 2015
Kind
B2
Abstract

A method of differentiating embryonic stem cells into neural and motor cells is disclosed. In one embodiment, the invention comprises culturing a population of cells comprising a majority of cells that are characterized by an early rosette morphology and are Sox1 − /Pax6 + in the presence of FGF2, FGF4, FGF8, FGF 9, or RA wherein the cells are characterized by an neural tube-like rosette morphology and are Pax6 + /Sox1 + .

Claims (8)

1. A method of generating a population of human forebrain dopamine neurons, comprising the steps of:

(a) providing a synchronous population of human Sox1−, Pax6+ cells characterized by an early rosette morphology;

(b) culturing the human Sox1−, Pax6+ cells of step (a) in the presence of fibroblast growth factor 2 (FGF2) for 4-6 days, wherein a population of cells expressing brain factor 1 (Bf1) and orthodenticle homeobox2 (Otx2) is generated;

(c) culturing the Bf1+ cells resulting from step (b) in the presence of sonic hedgehog (SHH) and FGF8 for 6-7 days; and

(d) culturing the cells resulting from step (c) in a neuronal differentiation medium to obtain a cell population in which about one third of the differentiated cells are human forebrain dopamine-producing neurons that express tyrosine hydroxylase (TH), aromatic acid decarboxylase (AADC), Bf1, Otx2, but do not express dopamine beta-hydroxylase (DβH) and phenylethanolamine N-methyltransferase (PNMT).

2. The method of claim 1 wherein FGF2 is present at a concentration of 10-20 ng/ml in step (b).

3. The method of claim 1 wherein SHH is present at a concentration of 50-250 ng/ml in step (c).

4. The method of claim 1 wherein the cells resulting from step (c) are exposed to the neuronal differentiation medium between 7-21 days.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2015
From: ZHANG, SU-CHUN; LI, XUE-JUN
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 035785/0796 →
CONFIRMATORY LICENSE Recorded Jul 25, 2011
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026639/0499 →
CONFIRMATORY LICENSE Recorded Jul 20, 2011
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026617/0767 →
Continuity (5)
Division 11594455 · Nov 8, 2006
Division 10928805 · Aug 27, 2004
Provisional Application 60498831 · Aug 29, 2003
Provisional Application 60499570 · Sep 2, 2003
Related Publication 20110275152A1 · Nov 10, 2011